soul trial oral semaglutide cardiovascular outcomes 2025 results Reduces CV Events in T2DM – (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine 🧪 T2DM + ASCVD/CKD 💊 Oral semaglutide 14 mg vs placebo 📉 soul trial oral semaglutide cardiovascular

But knowing what to expect at each dose level helps you manage symptoms proactively rather than reactively

doi:10.1111/bph.12490 62

Focus on eating balanced meals with plenty of calcium, vitamin D, and other vitamins that support oral health

Vimentin-null adipocytes showed 41.1% less CD36 on plasma membranes, 27% less uptake of fatty acids, and 50.3% less GLUT4, suggesting defects in intracellular trafficking of these molecules

It becomes "metabolically expensive" tissue that isn't being used

Tracking progress on a microdosing protocol Whether you choose standard dosing or microdosing, tracking your progress systematically helps you evaluate whether your protocol is working and make data-driven adjustments